本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 特一药业集团股份有限公司（以下简称"公司"）于 2025 年 7 月 16 日召开了 2025 年第二次临时股东会，选举产生了 5 名非职工代表董事，与公司于 2025 年 6 月 27 日召 开的公司职工代表大会选举产生的 1 名职工代表董事共同组成公司第六届董事会；同 日，公司召开了第六届董事会第一次会议，选举产生了公司董事长、董事会各专门委员 会成员及主任委员；经第六届董事会提名委员会审核及审计委员会审议，聘任了公司高 级管理人员、证券事务代表及审计部负责人。现将相关情况公告如下： 一、第六届董事会组成情况 公司第六届董事会由 6 名董事组成，其中非独立董事 4 名，独立董事 2 名，组成如 下： 证券代码：002728 证券简称：特一药业 公告编号：2025-049 特一药业集团股份有限公司 关于董事会完成换届选举及聘任高级管理人员、 证券事务代表、审计部负责人的公告 非独立董事：许荣煌先生（董事长）、陈习良先生、卢北京先生、姚如卿女士（职 工代表董事） 独立董事：赵晓波女士、赖瀚琪先生 第六届董事会中兼 ...

特一药业集团股份有限公司 董事会提名委员会 经审查，公司拟聘任高级管理人员提名已征得被提名人本人同意，提名程序符合《公 司法》和《公司章程》的有关规定，被提名人任职资格符合担任公司高级管理人员的条 件，能够胜任高级管理人员的职责要求，具备履行高级管理人员职责的能力。拟聘任高 级管理人员未受过中国证监会及其他有关部门的处罚和证券交易所纪律处分；不存在因 涉嫌犯罪被司法机关立案侦查或者涉嫌违法违规被中国证监会立案稽查，尚未有明确结 论的情形；不曾被中国证监会在证券期货市场违法失信信息公开查询平台公示或者被人 民法院纳入失信被执行人名单；不存在《深圳证券交易所上市公司自律监管指引第 1 号 ——主板上市公司规范运作》规定的不得被提名担任上市公司高级管理人员的情形。 除符合上述高级管理人员的任职条件外，本次拟聘任的董事会秘书候选人符合《公 司法》等相关法律、法规和规范性文件及《公司章程》规定的担任公司董事会秘书的条 件，能够胜任董事会秘书职务的职责要求，具备履行董事会秘书职责的专业胜任能力、 专业知识、工作经验和职业素养，熟悉履职相关法律法规和规则，具备与岗位要求相适 应的职业操守，具有良好的职业道德和个人品德。许紫 ...

证券代码：002728 证券简称：特一药业 公告编号：2025-047 特一药业集团股份有限公司 2025 年第二次临时股东会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 一、重要提示 1、本次股东会以现场表决与网络表决相结合的方式召开； 2、本次股东会未出现否决议案，未变更前次股东会决议； 3、本次会议无新议案提交表决。 二、会议召开情况 1、会议召集人：公司董事会 2、会议主持人：公司董事长许丹青 3、会议召开时间： （1）现场会议召开时间：2025 年 7 月 16 日下午 2:30； （2）网络投票时间： 2025 年 7 月 16 日，其中，通过深圳证券交易所交易系统进行网络投票的具体时间 为 2025 年 7 月 16 日 9:15—9:25，9:30—11:30 和 13:00—15:00；通过深圳证券交易 所互联网投票系统进行网络投票的具体时间为 2025 年 7 月 16 日 9:15-15:00 的任意时 间。 4、会议地点：广东省台山市台城长兴路 9、11 号特一药业集团股份有限公司二楼会 议室 5、召开方式：现场投票与网络投 ...

法律意见书 深圳市福田区深南大道6008号特区报业大厦42、41、31DE、2403、2405 电话(Tel):+86 755 83515666 传真(Fax):+86 755 83515333/83515090 网址(Website): www.grandall.com.cn 国浩律师（深圳）事务所 关于特一药业集团股份有限公司 2025年第二次临时股东会的法律意见书 GLG/SZ/A2957/FY/2025-877 致：特一药业集团股份有限公司 国浩律师（深圳）事务所（以下称"本所"）接受特一药业集团股份有限公 司（以下称"公司"）的委托，指派本所律师出席公司2025年第二次临时股东会 （以下称"本次股东会"），对本次股东会的合法性进行见证。 本所律师根据《中华人民共和国公司法》（以下称"《公司法》"）、《上 市公司股东会规则》（以下称"《股东会规则》"）等法律、法规和规范性法律 文件以及《特一药业集团股份有限公司章程》（以下称"《公司章程》"）的规 定，就公司本次股东会的召集、召开程序、出席会议人员的资格、召集人的资格、 表决程序和表决结果等有关事宜出具本法律意见书。 本法律意见书仅供公司本次股东会相关 ...

证券代码：002728 证券简称：特一药业 公告编号：2025-048 特一药业集团股份有限公司 关于第六届董事会第一次会议决议的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 一、董事会会议召开情况 特一药业集团股份有限公司（以下简称"公司"）于 2025 年 7 月 16 日召开 2025 年第二次临时股东会选举产生公司第六届董事会成员，为保证董事会工作的衔接性和连 贯性，公司第六届董事会第一次会议通知于当天以现场和通讯方式发出。会议于当日在 公司会议室采用现场及通讯方式召开，会议应出席董事 6 名，实际出席 6 名，其中卢北 京、赵晓波、赖瀚琪以通讯表决方式出席会议。公司非董事高级管理人员列席了本次会 议。会议的召集、召开符合《公司法》和《公司章程》的相关规定。 经公司过半数董事一致同意推举，会议由董事许荣煌主持，全体董事经过审议，以 现场及通讯方式进行表决，通过了如下决议： 1.00 审议通过《关于选举公司第六届董事会董事长的议案》 经审议，董事会同意选举许荣煌先生为公司第六届董事会董事长，董事长为代表公 司执行公司事务的董事，担任公司法定代表人 ...

Group 1 - The concept of Helicobacter pylori has seen an increase of 1.93%, ranking 9th among concept sectors, with 62 stocks rising, including Rundu Co., Aosaikang, and Zhejiang Zhenyuan hitting the daily limit [1][2] - Leading gainers in the Helicobacter pylori sector include Laimei Pharmaceutical, Hanyu Pharmaceutical, and Te Yi Pharmaceutical, with increases of 8.48%, 6.41%, and 5.49% respectively [1] - The sector experienced a net inflow of 774 million yuan from main funds, with 49 stocks receiving net inflows, and 8 stocks exceeding 50 million yuan in net inflow, led by Hanyu Pharmaceutical with 166 million yuan [2][3] Group 2 - The top three stocks by net inflow ratio are Rundu Co. at 42.20%, Zhejiang Zhenyuan at 29.25%, and ST Huluwa at 16.55% [3][4] - Hanyu Pharmaceutical had a trading volume of 165.89 million yuan with a net inflow ratio of 6.26%, while Rundu Co. had a trading volume of 144.66 million yuan [3][4] - The overall market performance shows a mixed trend, with some stocks like Zhijiang Biology, ST Suwu, and Dongfang Ocean experiencing declines of 6.08%, 5.02%, and 4.23% respectively [6][7]

Core Viewpoint - The article highlights significant developments in China's financial and economic landscape, including regulatory measures, monetary policy updates, trade statistics, and corporate earnings forecasts. Group 1: Regulatory and Policy Developments - The Central Committee of the Communist Party of China emphasizes strengthening financial trial work to combat market manipulation, insider trading, illegal fundraising, loan fraud, and money laundering, while also improving rules for emerging financial disputes [2] - The People's Bank of China (PBOC) has implemented a series of structural monetary policy tools to support technology innovation and consumption, with a total loan contract amount for technology innovation reaching 1.74 trillion yuan by the end of May [3] - The PBOC plans to conduct a 14 billion yuan reverse repurchase operation to maintain liquidity in the banking system [4] Group 2: Economic Indicators - As of June 2025, the broad money supply (M2) in China reached 330.29 trillion yuan, growing by 8.3% year-on-year, while the narrow money supply (M1) was 113.95 trillion yuan, up by 4.6% [2] - In the first half of 2025, the total social financing increased by 22.83 trillion yuan, which is 4.74 trillion yuan more than the same period last year [2] - China's goods trade in the first half of 2025 totaled 21.79 trillion yuan, a year-on-year increase of 2.9%, with exports at 13 trillion yuan (up 7.2%) and imports at 8.79 trillion yuan (down 2.7%) [4] Group 3: Corporate Earnings and Developments - China National Salt Industry Corporation reported a 5.76% decrease in revenue for the first half of 2025, with net profit down 88.04% to 52.72 million yuan [8] - Jinpu Titanium Industry plans to exit the titanium dioxide industry through significant asset swaps [9] - Qianfang Technology expects a net profit increase of 1125.99% to 1534.65% for the first half of 2025 [10] - Huahong Technology anticipates a net profit increase of 3047.48% to 3721.94% for the same period [11] - Aerospace Science and Technology Corporation projects a net profit increase of 1628.83% to 2315.27% for the first half of 2025 [19]

Group 1 - The first half of 2025 financial reports for A-share companies have been released, with many companies forecasting profit increases of over 10 times [1][5] - Zhongyan Chemical's report shows a revenue of 5.998 billion yuan, a year-on-year decrease of 5.76%, and a net profit of 52.7155 million yuan, down 88.04% year-on-year [3][4] - The decline in Zhongyan Chemical's revenue is attributed to intensified market competition and significant price drops in key products, despite a 38.82% increase in sales volume [3][4] Group 2 - Huahong Technology expects a net profit of 70 million to 85 million yuan for the first half of 2025, representing a year-on-year increase of 3047.48% to 3721.94% [6] - Wan Nianqing anticipates a net profit of 31 million to 45 million yuan, reflecting a year-on-year growth of 1954.07% to 2881.71% [7] - Other companies such as Yatai Pharmaceutical and Aerospace Science and Technology also project significant profit increases, with Yatai expecting a net profit of 100 million to 110 million yuan, up 1726.42% to 1909.06% year-on-year [7]

Core Viewpoint - The first half of 2025 financial reports from A-share listed companies reveal significant profit increases, with several companies projecting profit growth exceeding tenfold compared to the previous year [1][5]. Group 1: Company Performance - Zhongyan Chemical's 2025 half-year report shows a revenue of 5.998 billion yuan, a decrease of 5.76% year-on-year, with a net profit of 52.7155 million yuan, down 88.04% year-on-year [3][4]. - The decline in Zhongyan Chemical's revenue is attributed to intensified market competition and significant price drops in key products like soda ash and PVC, despite a 38.82% increase in sales volume [3][4]. - Huahong Technology expects a net profit of 70 million to 85 million yuan for the first half of 2025, representing a year-on-year increase of 3047.48% to 3721.94%, driven by improved prices of rare earth raw materials [6][7]. - Wannianqing anticipates a net profit of 31 million to 45 million yuan, reflecting a year-on-year growth of 1954.07% to 2881.71%, supported by recovering demand in the cement industry and cost reduction efforts [6][7]. - Other companies like Yatai Pharmaceutical and Aerospace Science and Technology also project substantial profit increases, with expected growth rates of 1726.42% to 1909.06% and 1628.83% to 2315.27%, respectively [7]. Group 2: Market Trends - The overall trend indicates a recovery in certain sectors, such as the cement industry, due to reduced declines in real estate investment and infrastructure spending [7]. - The chemical industry is experiencing price fluctuations, with some products seeing significant price drops due to weakened downstream demand, while others like caustic soda have increased prices due to demand pull [4].

Major Events - Zhonghua Equipment plans to acquire 100% equity of Yiyang Rubber and Plastic Machinery Group and Beihua Machinery, with stock suspension starting July 15, 2025 [3] - Suzhou Planning intends to purchase 100% equity of Dongjin Aerospace through a combination of cash and stock issuance, with stock resuming trading on July 15, 2025 [4] - Aerospace Development's independent director was detained for personal reasons unrelated to the company's operations, which remain stable [5][6] - *ST Tianmao issued a risk warning regarding potential delisting due to failure to disclose annual reports in time [7] - ST Shuntian will suspend trading for one day on July 15, 2025, and will remove other risk warnings, changing its stock name to Jiangsu Shuntian [8] - Xinghui Entertainment plans to transfer 99.66% equity of Espanyol Football Club for €130 million, focusing on core business areas [9] Performance Reports - China Salt Chemical reported a 5.76% decrease in revenue to ¥5.998 billion and an 88.04% drop in net profit to ¥52.71 million for the first half of 2025 [10] - Jiu Gui Jiu expects a net profit of ¥8 million to ¥12 million, down 90.08% to 93.39% year-on-year, with revenue around ¥560 million, a 43% decline [11] - Suli Co. anticipates a net profit of ¥72 million to ¥86 million, up 1008.39% to 1223.91% year-on-year, driven by increased sales and prices [12] - Te Yi Pharmaceutical expects a net profit of ¥34 million to ¥38 million, a growth of 1164.22% to 1312.95% year-on-year, due to strong sales of its core product [13] - Huahong Technology forecasts a net profit of ¥70 million to ¥85 million, up 3047.48% to 3721.94% year-on-year, benefiting from improved market conditions [14] - Qianfang Technology expects a net profit of ¥150 million to ¥200 million, an increase of 1125.99% to 1534.65% year-on-year, influenced by fair value changes of equity instruments [15] - Huaxia Airlines anticipates a net profit of ¥220 million to ¥290 million, up 741.26% to 1008.93% year-on-year, due to improved flight demand [16] - Xianfeng Holdings expects a net profit of ¥34 million to ¥42 million, a growth of 524.58% to 671.53% year-on-year, mainly from non-recurring gains [17] - Xinyi Sheng expects a net profit of ¥370 million to ¥420 million, up 327.68% to 385.47% year-on-year, driven by AI-related investments [18] - Haili Co. anticipates a net profit of ¥30.5 million to ¥36 million, a growth of 625.83% to 756.71% year-on-year, due to improved sales [19] - Hengsheng Electronics expects a net profit of approximately ¥251 million, an increase of about 740.95% year-on-year, due to significant non-recurring gains [20] - Tianqi Lithium expects a net profit of ¥0 to ¥155 million, recovering from a loss of ¥5.206 billion in the previous year [21] - Shui Jing Fang forecasts revenue of ¥1.498 billion, down 12.84%, and a net profit of ¥105 million, down 56.52% [22] - CICC expects a net profit of ¥3.453 billion to ¥3.966 billion, an increase of 55% to 78% year-on-year [23] - Shenwan Hongyuan anticipates a net profit of ¥4.1 billion to ¥4.5 billion, a growth of 92.66% to 111.46% year-on-year [24] - Xinda Securities expects a net profit of ¥921 million to ¥1.044 billion, an increase of 50% to 70% year-on-year [25] - Shanxi Securities anticipates a net profit of ¥504 million to ¥544 million, a growth of 58.17% to 70.72% year-on-year [26] - Guohai Securities expects a net profit of ¥370 million, a growth of 159.26% year-on-year [27] - Guocheng Mining anticipates a net profit of ¥493 million to ¥548 million, a growth of 1046.75% to 1174.69% year-on-year [28] - China Rare Earth expects a net profit of ¥136 million to ¥176 million, recovering from a loss of ¥244 million [29] - Perfect World anticipates a net profit of ¥480 million to ¥520 million, recovering from a loss of ¥177 million [30] - Fangda Carbon expects a net profit of ¥50 million to ¥60 million, down 65.13% to 70.93% year-on-year [31] - Huanghe Xuanfeng expects a net loss of ¥285 million [32] - JA Solar anticipates a net loss of ¥2.5 billion to ¥3 billion, worsening from a loss of ¥874 million [33] - Shanxi Black Cat expects a net loss of ¥490 million to ¥540 million [34] - Ganfeng Lithium anticipates a net loss of ¥300 million to ¥550 million, improving from a loss of ¥760 million [35] - Xinda Real Estate expects a net loss of ¥3.5 billion to ¥3.9 billion [36] - Greenland Holdings anticipates a net loss of ¥3 billion to ¥3.5 billion [37] - Air China expects a net loss of ¥1.7 billion to ¥2.2 billion [39] - OFILM expects a net loss of ¥85 million to ¥115 million [40] - Vanke A expects a net loss of ¥10 billion to ¥12 billion [41] Major Contracts - Zhongchen Co. won a project from Southern Power Grid worth ¥379 million, accounting for 12.26% of its 2024 audited revenue [42] - Gaode Infrared signed a procurement agreement worth ¥879 million, representing 32.84% of its 2024 audited revenue [43]